Q3 2024 Earnings Call Transcript November 7, 2024 BlackLine, Inc. beats earnings expectations. Reported EPS is $0.6, ...

Collegium Pharmaceutical Inc. ( (COLL)) has released its Q3 earnings. Here is a breakdown of the information Collegium Pharmaceutical Inc. presented to its investors. Collegium Pharmaceutical ...

South Korea’s reputable yet increasingly taxed healthcare industry depends on a robust pharmaceutical sector. As domestic and international demand has increased, the country has further proven ...

Ascendis Pharma (ASND) has released an update. Ascendis Pharma A/S has structured its capital to enable significant growth opportunities, with a current share capital of DKK 60,642,144.

Meanwhile, another crop of companies is deploying machine learning and artificial intelligence to the design and execution of clinical trials for existing drug candidates, hoping to see a much ...

and machine learning, adds new dimensions to data integrity. These technologies enable continuous improvement in pharmaceutical product manufacturing processes and require high-quality data inputs ...

GLP-1 receptor agonists and SGLT2 inhibitors, two classes of medications most commonly prescribed to treat Type 2 diabetes or weight loss, may reduce the risk of heart attack, second strokes and ...

Chris Rose of ProStrakan offers advice on selling in the pharmaceutical industry. The 80's and 90's spawned a host of selling models and most of us in the pharma business have been trained to use ...

The pharmaceutical value chain model depicted in Figure 1 covers a full range of activities that are required to bring a product from conception to final consumer. The key players in the chain are ...

Takeda, a Japanese pharmaceutical company with US headquarters in Cambridge, has announced the latest of several rounds of layoffs it’s been conducting this year, bringing the total to nearly ...

Pharmaceutical spectroscopy techniques like NMR, mass spectrometry, and UV-Vis play essential roles in pharmacokinetics, supporting each stage of drug development from discovery and preclinical ...

Vertex Pharmaceuticals is in the process of getting a new painkiller approved. It just published some data that suggests the candidate will be quite profitable. But regulators still need to sign ...